Keyphrases
Pharmacological Assays
100%
Primary Prevention
100%
Coronary Heart Disease Prevention
100%
Secondary Prevention
100%
Lipids
50%
Adverse Effects
50%
Platelets
50%
Lipoproteins
33%
Aspirin
33%
Non-fatal
33%
Clofibrate
33%
Nicotinic Acid
33%
Cigarette Smoking
16%
Incongruity
16%
Long-term Mortality
16%
Risk-benefit Ratio
16%
Plasma Lipids
16%
Cholesterol
16%
Middle-aged
16%
All-cause Mortality
16%
Resin
16%
Combined Therapy
16%
Dipyridamole
16%
Lipoprotein Metabolism
16%
Conjugated Equine Estrogens
16%
Lipid-lowering Drugs
16%
Death Events
16%
Stroke Event
16%
CHD Risk
16%
Mortality from All Causes
16%
No-place
16%
Cholestyramine
16%
Atherogenic Lipoproteins
16%
Early Termination
16%
Sedentary Living
16%
Secondary Prevention Trials
16%
Strategic Thrusts
16%
Lipid Reduction
16%
Mass Problems
16%
Epidemic Control
16%
Pharmacology, Toxicology and Pharmaceutical Science
Lipoprotein
100%
Ischemic Heart Disease
100%
Acetylsalicylic Acid
66%
Nicotinic Acid
66%
Clofibrate
66%
Diseases
66%
Conjugated Estrogen
33%
Cigarette Smoking
33%
Prematurity
33%
All Cause Mortality
33%
Antilipemic Agent
33%
Cerebrovascular Accident
33%
Colestyramine
33%
Dextrothyroxine
33%
Sulfinpyrazone
33%
Ethinylestradiol
33%
Cytidine Diphosphate
33%
Dipyridamole
33%